SG/PUT/AMGEN/250/0.1/17.01.25 Stock

DE000SY005U8

Market Closed - Bid/Ask 02:34:15 2024-07-11 am EDT			After market 02:00:36 pm
0.4 ^EUR	-13.04%		0.405	+1.25%

Current month	-2.13%
1 month	-37.84%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart AMGEN INC.

Latest news about AMGEN INC.

Morgan Stanley Adjusts Price Target on Amgen to $303 From $310	08:44am	MT
DexCom, Inc. : A Must-Have Tool for Diabetes Care	Jul. 10
Alvotech Says Study on Proposed Biosimilar to Prolia, Xgeva Meets Primary Endpoints	Jul. 02	MT
Amgen Inc.(NasdaqGS:AMGN) added to Russell 1000 Dynamic Index	Jun. 30	CI

More news

Quotes 5-day view

Date	Price	Change
24-07-11	0.4	-13.04%
24-07-10	0.46	-13.21%
24-07-09	0.53	0.00%
24-07-08	0.53	-1.85%
24-07-05	0.54	+1.89%

Delayed Quote Börse Stuttgart

Last update July 11, 2024 at 02:34 am EDT

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	PUT
Underlying	AMGEN INC.
Issuer	Société Générale
WKN	SY005U
ISIN	DE000SY005U8
Date issued	2024-05-29
Strike	250 $
Maturity	2025-01-17 (190 Days)
Parity	10 : 1
Emission price	0.8 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.96 €
Lowest since issue	0.4 €
Spread	0.01 €
Spread %	2.50%

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.

Sector

More about the company

Ratings for Amgen Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Consensus: Amgen Inc.

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

321.7 USD

Average target price

316.1 USD

Spread / Average Target

-1.72%

Consensus